Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide 15 mg represents the cutting edge in metabolic peptide science — a triple-agonist targeting GLP-1, GIP, and glucagon receptors for unmatched fat-burning, appetite control, and metabolic optimization.
This next-generation formulation goes beyond single-pathway peptides to deliver comprehensive results across energy, metabolism, and body composition.
Retatrutide 15 mg represents the cutting edge in metabolic peptide science — a triple-agonist targeting GLP-1, GIP, and glucagon receptors for unmatched fat-burning, appetite control, and metabolic optimization.
This next-generation formulation goes beyond single-pathway peptides to deliver comprehensive results across energy, metabolism, and body composition.
